Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
Hongjuan Dong, Shanghua Fan, Ying Luo, Bin Peng Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China Objective: To explore the efficacy of botulinum toxin type A (BTX-A) therapy in relieving anxiety and depression in patients with hemifacial spasm (HFS) and benign esse...
Guardado en:
Autores principales: | Dong H, Fan S, Luo Y, Peng B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34f9adf5d1594de0ba499b95466ac112 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A
por: Jariyakosol S, et al.
Publicado: (2021) -
Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
por: Yin B, et al.
Publicado: (2021) -
Evaluation of Intraocular Pressure After Water Drinking Test in Patients with Unilateral Hemifacial Spasm
por: Low JR, et al.
Publicado: (2020) -
Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
por: Jeongkyeong Jang, et al.
Publicado: (2021) -
Depression in blepharospasm: a question of facial feedback?
por: Bedarf JR, et al.
Publicado: (2017)